Monday, December 19, 2016 7:31:15 AM
Of course I don't know how she explained things other than what was in the PowerPoint presentation.
Is diabetes curable in the future?
Diabetes type 1 therapy by transplantation
encapsulated insulin-producing cells
Dr. Eva Maria (Lilli) Brandtner
VIVIT Vorarlberg
BioLAGO science meets industry
Constance, 15th December 2016
What is type 1 diabetes?
healthy type 1 diabetes
Immune cells
destroy insulin
producing
Beta cells
Can pancreas
No insulin
produce
more glucose in your blood goes to insulin
the cells
Pancreas
produces
Insulin
Glucose
joshya/Shutterstock.com
Picture dwarf - Fotolia.com
High blood pressure, sexual disorders, etc.
SYMPTOMS
• Frequent urination
• Strong thirst
• Weight loss
• Malaise, fatigue, and weakness
• Blurred vision
• Loss of consciousness
unknown
< 2 2-5 5-10 10-25 > 25
Around the world (by 2015):
415 million adults
500 000 children
5-10% OF T1D
3% global increase of T1D Neuerkrankugen per year
International Diabetes Federation
T1D new disease per 100,000 children per year
International Diabetes Federation
Who has diabetes?
Is diabetes curable?
Betazell transplantation
• Treatment by injection of insulin / insulin pumps
• Advanced cases of type 2 diabetes
• Healing: pancreatic and Betazell transplantation
• today: only about 1000 patients worldwide transplanted
• Shortage of donor organs:
1 transplant/625 T1DM patients. 2-4 Pankreata/patient
• Serious risks and side effects of immune supprimierenden
Medications for graft rejection
What can cell encapsulation?
Sugar
Insulin
Immune
Cells
• allows the transplant of alien cells without immune supprimierende
Medicines
• Diameter: 0.7 mm
• contains up to 10,000 cells
Cellulose sulphate capsules
• electron microscopic images
• on cotton basis
• can be frozen (including cells)
confidential data
Does it work?
Blood sugar levels of animals under the following conditions:
(?) diabetic control group (n = 5).
(?) animals with graft, Explantation of capsules on day 15 (n = 5)
(?) Explantation of capsules at day 45 (n = 5)
(?) Explantation of capsules at day 150 (n = 5)
Time (days)
Blood glucose (mg/dl)
Try encapsulated pig beta cells in diabetic rats
All transplanted animals had normal blood sugar levels during the entire
Test duration (150 days) or until the grafts were removed.
What kind of cells?
MELL-CELLS UTS Australia
• Liver cells: robust
• genetically modified so that they make insulin,
Save and increased blood sugar levels
unlock
pmol insulin/10 6 cells
Glucose (mmol/l)
Insulin secretion
(relative to the level before the stimulation)
Group number
Start the stimulation
(20 mM glucose)
At the end of the
Stimulation
Prof. Dr. Walter Günzburg
Dr Brian Salmons
Dr. John Dangerfield
Dr. Kenneth L. Waggoner
Dr. Gerald W. Crabtree
Dr. Eva Maria Brandtner
Prof. Dr. Matt Löhr
Prof. Axel
Kornerup Hansen
Prof. Dr. Ann Simpson
Dr. Brenton Hadi
Dr. Constantine Konstantoulas
Prof. Dr. Thomas Stratmann
Prof. Dr. Rüdiger Wanke
Prof. Dr. Eckhard Wolf
Dr. Andreas Blutke
This research was supported by a
Marie Curie FP7 integration Grant as part of the 7th European framework programme
Recent PMCB News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/13/2024 08:37:40 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 07/29/2024 08:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:59:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:35 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:05:04 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/30/2024 08:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:40:20 PM
- PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease • Business Wire • 05/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM